Arkhangelsk

Futó vizsgálatok

• Toboroz

  TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation

  NCT07038928· Forrás

• Toboroz

  Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration

  NCT07052578· Forrás

• Toboroz

  An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation

  NCT07041606· Forrás

• Toboroz

  Clinical and Demographic Characteristics of Adult p Atients With NEurofibromatosis in RUSsia

  NCT07088991· Forrás

• Fut, nem toboroz

  A Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (IVOLGA)

  NCT06943833· 2. fázis· Forrás

• Fut, nem toboroz

  Treatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic Alterations

  NCT06245837· Forrás

• Fut, nem toboroz

  CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia

  NCT05887011· Forrás

• Fut, nem toboroz

  A Multi-center, Non-interventional, Prospective Study of Durvalumab in Unresectable Locally Advanced NSCLC in Routine Clinical Practice in Russia

  NCT05456867· Forrás

• Fut, nem toboroz

  D9319C00001- 1L OC Mono Global RCT

  NCT04884360· 3. fázis· Forrás

• Fut, nem toboroz

  Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC

  NCT03997123· 3. fázis· Forrás

• Fut, nem toboroz

  Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)

  NCT03775486· 2. fázis· Forrás

• Fut, nem toboroz

  Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL)

  NCT03003962· 3. fázis· Forrás

• Fut, nem toboroz

  AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.

  NCT02511106· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Hólyagrák1 toboroz
• Méhtestrák1 toboroz
• Prosztatarák1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  Hereditary Transthyretin Amyloidosis Polyneuropathy in Patients With Carpal Tunnel Syndrome in Russia

  NCT06414746· Forrás

• Lezárult

  A Non-interventional Prospective Study of 1-st Line Treatment Approaches in OVArian Cancer Patients With HRD+ Status in Russian Federation

  NCT05918042· Forrás

• Lezárult

  HER2(Human Epidermal Growth Factor Receptor 2) -Positive Metastatic Breast Cancer in Russia

  NCT05905939· Forrás

• Lezárult

  HER2-low Unresectable and/or Metastatic Breast Cancer in Russia

  NCT05913440· Forrás

• Leállították

  Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab in First Line Metastatic Non-squamous NSCLC

  NCT04786964· 3. fázis· Forrás

• Lezárult

  Heart Failure Patients Registry

  NCT04709263· Forrás

• Lezárult

  Durvalumab Long-Term Safety and Efficacy Study

  NCT04078152· 4. fázis· Forrás

• Lezárult

  Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer

  NCT03519971· 3. fázis· Forrás

• Lezárult

  Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.

  NCT02000622· 3. fázis· Forrás